Why is Concord Drugs falling/rising?

As of 11-Nov, Concord Drugs Ltd's stock price is rising, currently at Rs. 85.51, reflecting an increase of Rs. 7.76 or 9.98%. The stock has recently hit a new 52-week high of Rs. 85.52 and has been gaining for the last two days, with a notable return of 20.96% during this period. Additionally, the stock has outperformed its sector by 10.11% today. Over the past year, Concord Drugs has shown impressive returns, with a year-to-date increase of 125.03% and a one-year return of 130.17%. The stock is also trading above all its moving averages, indicating strong momentum. Furthermore, there has been a significant rise in investor participation, with delivery volume increasing by 126.71% compared to the five-day average, suggesting heightened interest in the stock.
In the broader market context, Concord Drugs has outperformed the Sensex, which has only increased by 0.49% over the past week, while Concord Drugs has surged by 20.45% in the same timeframe. This stark contrast highlights the stock's strong performance relative to the benchmark. The high volatility observed today, with an intraday volatility of 5.24%, indicates active trading and investor engagement, contributing to the stock's upward movement. Overall, the combination of strong returns, increased investor participation, and favorable trading conditions has driven the stock price higher.